Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based TherapyNutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitusRecruitingPhase 22026-06-15NCT07502508

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Biomea Fusion Inc.3

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Ark Clinical ResearchLong BeachUnited States20
Burke Internal Medicine and ResearchBurkeUnited States5
Catalina Research Institute, LLCMontclairUnited States17
Central Research Associates, LLC dba Flourish ResearchBirminghamUnited States3
David Kavtaradze MD, IncCordeleUnited States2
Diabetes & Glandular Disease Clinic, P.A.San AntonioUnited States5
Diabetes and Endocrinology Associates of Stark CountyCantonUnited States2
Elligo Health Research, Inc.AustinUnited States3
Epic Clinical ResearchLewisvilleUnited States17
Excel Clinical ResearchLas VegasUnited States19
Flourish Research OrlandoWinter ParkUnited States1
Hope Clinical ResearchCanoga ParkUnited States14
Panax Clinical ResearchMiami LakesUnited States10
Paradigm Clinical Research Centers, LLCSan DiegoUnited States6
Southwest General Healthcare CenterFort MyersUnited States9
Synergy Group MedicalHoustonUnited States1
Zenos Clinical ResearchDallasUnited States27